Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrysos

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
Sexually Transmitted Infections|June 21, 2020
Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in GreeceEvangelia Georgia Kostaki, Ioannis Hodges-Mameletzis, Gkikas Magiorkinis, et al.
Plos One|April 6, 2017
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllersFanny Chereau, Yoann Madec, Caroline Sabin, et al.
Infectious Diseases and Therapy|August 7, 2021
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm TrialKonstantinos Tsiakos, Antonios Tsakiris, Georgios Tsibris, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
The Lancet. Respiratory Medicine|January 6, 2024
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trialEvangelos J Giamarellos-Bourboulis, Athanasios Siampanos, Amalia Bolanou, et al.
Viruses|October 22, 2020
A Nationwide Study about the Dispersal Patterns of the Predominant HIV-1 Subtypes A1 and B in Greece: Inference of the Molecular Transmission ClustersEvangelia Georgia Kostaki, Maria Gova, Georgios Adamis, et al.
HIV Medicine|October 19, 2022
Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factorsEvangelia Georgia Kostaki, Stefanos Limnaios, Georgios Adamis, et al.
Viruses|January 22, 2022
Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in EuropeStefanos Limnaios, Evangelia Georgia Kostaki, Georgios Adamis, et al.
The Journal of Infectious Diseases|December 11, 2012
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes, Dominique Costagliola, Bruno Ledergerber, et al.
International Journal of Antimicrobial Agents|December 8, 2024
Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the hostEvdoxia Kyriazopoulou, Karolina Akinosoglou, Eleni Florou, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Sexually Transmitted Infections|June 21, 2020
Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in GreeceEvangelia Georgia Kostaki, Ioannis Hodges-Mameletzis, Gkikas Magiorkinis, et al.
Plos One|April 6, 2017
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllersFanny Chereau, Yoann Madec, Caroline Sabin, et al.
Infectious Diseases and Therapy|August 7, 2021
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm TrialKonstantinos Tsiakos, Antonios Tsakiris, Georgios Tsibris, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
The Lancet. Respiratory Medicine|January 6, 2024
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trialEvangelos J Giamarellos-Bourboulis, Athanasios Siampanos, Amalia Bolanou, et al.
Viruses|October 22, 2020
A Nationwide Study about the Dispersal Patterns of the Predominant HIV-1 Subtypes A1 and B in Greece: Inference of the Molecular Transmission ClustersEvangelia Georgia Kostaki, Maria Gova, Georgios Adamis, et al.
HIV Medicine|October 19, 2022
Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factorsEvangelia Georgia Kostaki, Stefanos Limnaios, Georgios Adamis, et al.
Viruses|January 22, 2022
Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in EuropeStefanos Limnaios, Evangelia Georgia Kostaki, Georgios Adamis, et al.
The Journal of Infectious Diseases|December 11, 2012
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes, Dominique Costagliola, Bruno Ledergerber, et al.
International Journal of Antimicrobial Agents|December 8, 2024
Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the hostEvdoxia Kyriazopoulou, Karolina Akinosoglou, Eleni Florou, et al.
Pageof 20